Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 52 entries
Sorted by: Best Match Show Resources per page
Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP

Build and Broaden 3.0 AND Program Evaluation

Aronoff DM, Canetti C.
GSID: dTvz6S0n6-wJ
DM Aronoff, C Canetti… - The Journal of …, 2004 - Am Assoc Immnol

Prostaglandin E 2 is a potent lipid mediator of inflammation that effects changes in cell functions through ligation of four distinct G protein-coupled receptors (E-prostanoid (EP) 1, EP2, EP3, and EP4). During pneumonia, PGE 2 production is enhanced. In...

Cite
Aronoff, D. M., Canetti, C., & Peters-Golden, M. (2004). Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. The Journal of Immunology, 173(1), 559-565.
Aronoff, David M., Claudio Canetti, and Marc Peters-Golden. "Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP." The Journal of Immunology 173.1 (2004): 559-565.
Copy Download .nbib Format: MLA
Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

JCI insight

Granoff DM, Giuntini S, Gowans FA, Lujan E, Sharkey K, Beernink PT.
PMID: 27668287
JCI Insight. 2016 Sep 08;1(14):e88907. doi: 10.1172/jci.insight.88907.

Meningococcal factor H-binding protein (FHbp) is an antigen in 2 serogroup B meningococcal vaccines. FHbp specifically binds human and some nonhuman primate complement FH. To investigate the effect of binding of FH to FHbp on protective antibody responses, we...

Cite
Granoff DM, Giuntini S, Gowans FA, et al. Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight. 2016;1(14):e88907doi: 10.1172/jci.insight.88907.
Granoff, D. M., Giuntini, S., Gowans, F. A., Lujan, E., Sharkey, K., & Beernink, P. T. (2016). Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI insight, 1(14), e88907. https://doi.org/10.1172/jci.insight.88907
Granoff, Dan M, et al. "Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding." JCI insight vol. 1,14 (2016): e88907. doi: https://doi.org/10.1172/jci.insight.88907
Granoff DM, Giuntini S, Gowans FA, Lujan E, Sharkey K, Beernink PT. Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight. 2016 Sep 08;1(14):e88907. doi: 10.1172/jci.insight.88907. PMID: 27668287; PMCID: PMC5033880.
Copy Download .nbib Format: NLM
Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation.

Genome announcements

Singh P, Aronoff DM, Davies HD, Manning SD.
PMID: 26950320
Genome Announc. 2016 Feb 25;4(1). doi: 10.1128/genomeA.00015-16.

This report provides the whole-genome sequence of Streptococcus agalactiae isolate GB00037 isolated from a newborn in Calgary, Canada. This serotype V isolate is unique because it lacks pigment production previously shown to be critical for S. agalactiae virulence.

Cite
Singh P, Aronoff DM, Davies HD, et al. Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation. Genome Announc. 2016;4(1)doi: 10.1128/genomeA.00015-16.
Singh, P., Aronoff, D. M., Davies, H. D., & Manning, S. D. (2016). Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation. Genome announcements, 4(1), . https://doi.org/10.1128/genomeA.00015-16
Singh, Pallavi, et al. "Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation." Genome announcements vol. 4,1 (2016). doi: https://doi.org/10.1128/genomeA.00015-16
Singh P, Aronoff DM, Davies HD, Manning SD. Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation. Genome Announc. 2016 Feb 25;4(1). doi: 10.1128/genomeA.00015-16. PMID: 26950320; PMCID: PMC4767910.
Copy Download .nbib Format: NLM
Hayflick-NIH Settlement.

Science (New York, N.Y.)

Strehler BL, Abraham S, Bayreuther K, Bienenstock A, Binstock R, Birren J, Blumenthal HT, Brautbar C, Brody EM, Brody H, Comfort A, Cottle RW, Danielli JF, Danon D, Datan N, Ebbesen P, Elsen A, Freundt EA, Gallop PM, Girardi AJ, Glenn PF, Goheen JD, Goldstein S, Good RA, Goodlin RC, Granoff A, Gray A, Haber PA, Hamparian VV, Hijmans W, Holliday R, Horvath SM, Houck JC, Huebner RJ, Itoh H, Jukes T, Kaplan HS, Kirkman H, Kuwert E, Leiderman PH, Liss A, Litwin J, Lubin B, Macieira-Coelho A, Madoff S, Maletta GJ, Maramorosch K, Martin GM, Masover G, Matsumura T, Medvedev Z, Melnick JL, Merchant DJ, Namba M, Neter E, Neugarten B, Orgel L, Outschoorn AS, Pace DM, Packer L, Parker JC, Patterson MD, Pollard M, Portnuff J, Razin S, Reiff TR, Robert L, Rockstein M, Rosamoff H, Rosanoff EI, Rottem S, Schachter J, Schwartz H, Shanas E, Shimkin MB, Smith JR, Somerson NL, Stinebring W, Textor R, Thomas L, Viidik A, Weg R, Yabrov A, Yanofsky C, Zatz LM.
PMID: 17784330
Science. 1982 Jan 15;215(4530):240-2. doi: 10.1126/science.215.4530.240-b.

No abstract available.

Cite
Strehler BL, Abraham S, Bayreuther K, et al. Hayflick-NIH Settlement. Science. 1982;215(4530):240-2doi: 10.1126/science.215.4530.240-b.
Strehler, B. L., Abraham, S., Bayreuther, K., Bienenstock, A., Binstock, R., Birren, J., Blumenthal, H. T., Brautbar, C., Brody, E. M., Brody, H., Comfort, A., Cottle, R. W., Danielli, J. F., Danon, D., Datan, N., Ebbesen, P., Elsen, A., Freundt, E. A., Gallop, P. M., Girardi, A. J., Glenn, P. F., Goheen, J. D., Goldstein, S., Good, R. A., Goodlin, R. C., Granoff, A., Gray, A., Haber, P. A., Hamparian, V. V., Hijmans, W., Holliday, R., Horvath, S. M., Houck, J. C., Huebner, R. J., Itoh, H., Jukes, T., Kaplan, H. S., Kirkman, H., Kuwert, E., Leiderman, P. H., Liss, A., Litwin, J., Lubin, B., Macieira-Coelho, A., Madoff, S., Maletta, G. J., Maramorosch, K., Martin, G. M., Masover, G., Matsumura, T., Medvedev, Z., Melnick, J. L., Merchant, D. J., Namba, M., Neter, E., Neugarten, B., Orgel, L., Outschoorn, A. S., Pace, D. M., Packer, L., Parker, J. C., Patterson, M. D., Pollard, M., Portnuff, J., Razin, S., Reiff, T. R., Robert, L., Rockstein, M., Rosamoff, H., Rosanoff, E. I., Rottem, S., Schachter, J., Schwartz, H., Shanas, E., Shimkin, M. B., Smith, J. R., Somerson, N. L., Stinebring, W., Textor, R., Thomas, L., Viidik, A., Weg, R., Yabrov, A., Yanofsky, C., & Zatz, L. M. (1982). Hayflick-NIH Settlement. Science (New York, N.Y.), 215(4530), 240-2. https://doi.org/10.1126/science.215.4530.240-b
Strehler, B L, et al. "Hayflick-NIH Settlement." Science (New York, N.Y.) vol. 215,4530 (1982): 240-2. doi: https://doi.org/10.1126/science.215.4530.240-b
Strehler BL, Abraham S, Bayreuther K, Bienenstock A, Binstock R, Birren J, Blumenthal HT, Brautbar C, Brody EM, Brody H, Comfort A, Cottle RW, Danielli JF, Danon D, Datan N, Ebbesen P, Elsen A, Freundt EA, Gallop PM, Girardi AJ, Glenn PF, Goheen JD, Goldstein S, Good RA, Goodlin RC, Granoff A, Gray A, Haber PA, Hamparian VV, Hijmans W, Holliday R, Horvath SM, Houck JC, Huebner RJ, Itoh H, Jukes T, Kaplan HS, Kirkman H, Kuwert E, Leiderman PH, Liss A, Litwin J, Lubin B, Macieira-Coelho A, Madoff S, Maletta GJ, Maramorosch K, Martin GM, Masover G, Matsumura T, Medvedev Z, Melnick JL, Merchant DJ, Namba M, Neter E, Neugarten B, Orgel L, Outschoorn AS, Pace DM, Packer L, Parker JC, Patterson MD, Pollard M, Portnuff J, Razin S, Reiff TR, Robert L, Rockstein M, Rosamoff H, Rosanoff EI, Rottem S, Schachter J, Schwartz H, Shanas E, Shimkin MB, Smith JR, Somerson NL, Stinebring W, Textor R, Thomas L, Viidik A, Weg R, Yabrov A, Yanofsky C, Zatz LM. Hayflick-NIH Settlement. Science. 1982 Jan 15;215(4530):240-2. doi: 10.1126/science.215.4530.240-b. PMID: 17784330.
Copy Download .nbib Format: NLM
Welcome to Infectious Disease Reports: a message from the Editor.

Infectious disease reports

Aronoff DM.
PMID: 24470879
Infect Dis Rep. 2009 Sep 14;1(1):e1. doi: 10.4081/idr.2009.e1. eCollection 2009 Sep 14.

No abstract available.

Cite
Aronoff DM. Welcome to Infectious Disease Reports: a message from the Editor. Infect Dis Rep. 2009;1(1):e1doi: 10.4081/idr.2009.e1.
Aronoff, D. M. (2009). Welcome to Infectious Disease Reports: a message from the Editor. Infectious disease reports, 1(1), e1. https://doi.org/10.4081/idr.2009.e1
Aronoff, David M. "Welcome to Infectious Disease Reports: a message from the Editor." Infectious disease reports vol. 1,1 (2009): e1. doi: https://doi.org/10.4081/idr.2009.e1
Aronoff DM. Welcome to Infectious Disease Reports: a message from the Editor. Infect Dis Rep. 2009 Sep 14;1(1):e1. doi: 10.4081/idr.2009.e1. eCollection 2009 Sep 14. PMID: 24470879; PMCID: PMC3892566.
Copy Download .nbib Format: NLM
Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA.

Infectious disease reports

Jain R, Walk ST, Aronoff DM, Young VB, Newton DW, Chenoweth CE, Washer LL.
PMID: 24470956
Infect Dis Rep. 2013 Mar 19;5(1):e5. doi: 10.4081/idr.2013.e5. eCollection 2013 Jan 22.

The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) in our hospital increased beginning in 2009. We aimed to study the clinical and molecular epidemiology of these emerging isolates. We performed a retrospective review of all adult patients with clinical cultures confirmed...

Cite
Jain R, Walk ST, Aronoff DM, et al. Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA. Infect Dis Rep. 2013;5(1):e5doi: 10.4081/idr.2013.e5.
Jain, R., Walk, S. T., Aronoff, D. M., Young, V. B., Newton, D. W., Chenoweth, C. E., & Washer, L. L. (2013). Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA. Infectious disease reports, 5(1), e5. https://doi.org/10.4081/idr.2013.e5
Jain, Ruchika, et al. "Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA." Infectious disease reports vol. 5,1 (2013): e5. doi: https://doi.org/10.4081/idr.2013.e5
Jain R, Walk ST, Aronoff DM, Young VB, Newton DW, Chenoweth CE, Washer LL. Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA. Infect Dis Rep. 2013 Mar 19;5(1):e5. doi: 10.4081/idr.2013.e5. eCollection 2013 Jan 22. PMID: 24470956; PMCID: PMC3892616.
Copy Download .nbib Format: NLM
Variation in Macrophage Phagocytosis of .

Pathogens & immunity

Rogers LM, Gaddy JA, Manning SD, Aronoff DM.
PMID: 29930990
Pathog Immun. 2018;3(1):63-71. Epub 2018 May 18.

BACKGROUND: Group B METHODS: A high-throughput screen using the phorbol ester-differentiated THP-1 macrophage-like human cell line was used to quantify phagocytosis of a diverse group of 35 different human clinical isolates of GBS representing a wide variety of capsular...

Cite
Rogers LM, Gaddy JA, Manning SD, et al. Variation in Macrophage Phagocytosis of . Pathog Immun. 2018;3(1):63-71
Rogers, L. M., Gaddy, J. A., Manning, S. D., & Aronoff, D. M. (2018). Variation in Macrophage Phagocytosis of . Pathogens & immunity, 3(1), 63-71.
Rogers, Lisa M, et al. "Variation in Macrophage Phagocytosis of ." Pathogens & immunity vol. 3,1 (2018): 63-71.
Rogers LM, Gaddy JA, Manning SD, Aronoff DM. Variation in Macrophage Phagocytosis of . Pathog Immun. 2018;3(1):63-71. Epub 2018 May 18. PMID: 29930990; PMCID: PMC6007880.
Copy Download .nbib Format: NLM
Flow-through Omental Flap for Vascularized Lymph Node Transfer: A Novel Surgical Approach for Delayed Lymphatic Reconstruction.

Plastic and reconstructive surgery. Global open

Johnson AR, Bravo MG, Granoff MD, Kang CO, Critchlow JF, Tsai LL, Lee BT, Singhal D.
PMID: 31741817
Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2436. doi: 10.1097/GOX.0000000000002436. eCollection 2019 Sep.

The vascularized omental free flap has been described as a reliable option for the treatment of peripheral lymphedema. However, the flap has been associated with venous hypertension which may require venous supercharging or intra-flap arteriovenous fistula creation to offload...

Cite
Johnson AR, Bravo MG, Granoff MD, et al. Flow-through Omental Flap for Vascularized Lymph Node Transfer: A Novel Surgical Approach for Delayed Lymphatic Reconstruction. Plast Reconstr Surg Glob Open. 2019;7(9):e2436doi: 10.1097/GOX.0000000000002436.
Johnson, A. R., Bravo, M. G., Granoff, M. D., Kang, C. O., Critchlow, J. F., Tsai, L. L., Lee, B. T., & Singhal, D. (2019). Flow-through Omental Flap for Vascularized Lymph Node Transfer: A Novel Surgical Approach for Delayed Lymphatic Reconstruction. Plastic and reconstructive surgery. Global open, 7(9), e2436. https://doi.org/10.1097/GOX.0000000000002436
Johnson, Anna Rose, et al. "Flow-through Omental Flap for Vascularized Lymph Node Transfer: A Novel Surgical Approach for Delayed Lymphatic Reconstruction." Plastic and reconstructive surgery. Global open vol. 7,9 (2019): e2436. doi: https://doi.org/10.1097/GOX.0000000000002436
Johnson AR, Bravo MG, Granoff MD, Kang CO, Critchlow JF, Tsai LL, Lee BT, Singhal D. Flow-through Omental Flap for Vascularized Lymph Node Transfer: A Novel Surgical Approach for Delayed Lymphatic Reconstruction. Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2436. doi: 10.1097/GOX.0000000000002436. eCollection 2019 Sep. PMID: 31741817; PMCID: PMC6799400.
Copy Download .nbib Format: NLM
Lipofilling after breast conserving surgery: a plastic surgery perspective.

Gland surgery

Granoff MD, Guo L, Singhal D.
PMID: 32775249
Gland Surg. 2020 Jun;9(3):617-619. doi: 10.21037/gs.2020.04.02.

No abstract available.

Cite
Granoff MD, Guo L, Singhal D. Lipofilling after breast conserving surgery: a plastic surgery perspective. Gland Surg. 2020;9(3):617-619doi: 10.21037/gs.2020.04.02.
Granoff, M. D., Guo, L., & Singhal, D. (2020). Lipofilling after breast conserving surgery: a plastic surgery perspective. Gland surgery, 9(3), 617-619. https://doi.org/10.21037/gs.2020.04.02
Granoff, Melisa D, et al. "Lipofilling after breast conserving surgery: a plastic surgery perspective." Gland surgery vol. 9,3 (2020): 617-619. doi: https://doi.org/10.21037/gs.2020.04.02
Granoff MD, Guo L, Singhal D. Lipofilling after breast conserving surgery: a plastic surgery perspective. Gland Surg. 2020 Jun;9(3):617-619. doi: 10.21037/gs.2020.04.02. PMID: 32775249; PMCID: PMC7347831.
Copy Download .nbib Format: NLM
Acupuncture and Integrative Medicine in Pediatrics.

Medical acupuncture

Tsai SL, Niemtzow RC, Brown M, Gold MA, Graff DM, Quah-Smith I, McClafferty H.
PMID: 29937956
Med Acupunct. 2018 Apr 01;30(2):61-67. doi: 10.1089/acu.2018.29075.rtl.

No abstract available.

Cite
Tsai SL, Niemtzow RC, Brown M, et al. Acupuncture and Integrative Medicine in Pediatrics. Med Acupunct. 2018;30(2):61-67doi: 10.1089/acu.2018.29075.rtl.
Tsai, S. L., Niemtzow, R. C., Brown, M., Gold, M. A., Graff, D. M., Quah-Smith, I., & McClafferty, H. (2018). Acupuncture and Integrative Medicine in Pediatrics. Medical acupuncture, 30(2), 61-67. https://doi.org/10.1089/acu.2018.29075.rtl
Tsai, Shiu-Lin, et al. "Acupuncture and Integrative Medicine in Pediatrics." Medical acupuncture vol. 30,2 (2018): 61-67. doi: https://doi.org/10.1089/acu.2018.29075.rtl
Tsai SL, Niemtzow RC, Brown M, Gold MA, Graff DM, Quah-Smith I, McClafferty H. Acupuncture and Integrative Medicine in Pediatrics. Med Acupunct. 2018 Apr 01;30(2):61-67. doi: 10.1089/acu.2018.29075.rtl. PMID: 29937956; PMCID: PMC6011360.
Copy Download .nbib Format: NLM
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN.

medRxiv : the preprint server for health sciences

Peetluk LS, Rebeiro PF, Edwards KM, Banerjee R, Mallal SA, Aronoff DM, Lipworth L, Katz SE.
PMID: 34790987
medRxiv. 2021 Nov 10; doi: 10.1101/2021.11.09.21266140.

BACKGROUND: The COVID-19 pandemic has greatly impacted school operations. To better understand the role of schools in COVID-19 transmission, we evaluated infections at two independent schools in Nashville, TN during the 2020-2021 school year.METHODS: The cumulative incidence of COVID-19...

Cite
Peetluk LS, Rebeiro PF, Edwards KM, et al. Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN. medRxiv. 2021;doi: 10.1101/2021.11.09.21266140.
Peetluk, L. S., Rebeiro, P. F., Edwards, K. M., Banerjee, R., Mallal, S. A., Aronoff, D. M., Lipworth, L., & Katz, S. E. (2021). Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.11.09.21266140
Peetluk, Lauren S, et al. "Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.11.09.21266140
Peetluk LS, Rebeiro PF, Edwards KM, Banerjee R, Mallal SA, Aronoff DM, Lipworth L, Katz SE. Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN. medRxiv. 2021 Nov 10; doi: 10.1101/2021.11.09.21266140. PMID: 34790987; PMCID: PMC8597896.
Copy Download .nbib Format: NLM
Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus.

Chembiochem : a European journal of chemical biology

Lu J, Francis JD, Guevara MA, Moore RE, Chambers SA, Doster RS, Eastman AJ, Rogers LM, Noble KN, Manning SD, Damo SM, Aronoff DM, Townsend SD, Gaddy JA.
PMID: 33755306
Chembiochem. 2021 Jun 15;22(12):2124-2133. doi: 10.1002/cbic.202100016. Epub 2021 Mar 23.

Group B Streptococcus (GBS) is an encapsulated Gram-positive human pathogen that causes invasive infections in pregnant hosts and neonates, as well as immunocompromised individuals. Colonization of the human host requires the ability to adhere to mucosal surfaces and circumnavigate...

Cite
Lu J, Francis JD, Guevara MA, et al. Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus. Chembiochem. 2021;22(12):2124-2133doi: 10.1002/cbic.202100016.
Lu, J., Francis, J. D., Guevara, M. A., Moore, R. E., Chambers, S. A., Doster, R. S., Eastman, A. J., Rogers, L. M., Noble, K. N., Manning, S. D., Damo, S. M., Aronoff, D. M., Townsend, S. D., & Gaddy, J. A. (2021). Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus. Chembiochem : a European journal of chemical biology, 22(12), 2124-2133. https://doi.org/10.1002/cbic.202100016
Lu, Jacky, et al. "Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus." Chembiochem : a European journal of chemical biology vol. 22,12 (2021): 2124-2133. doi: https://doi.org/10.1002/cbic.202100016
Lu J, Francis JD, Guevara MA, Moore RE, Chambers SA, Doster RS, Eastman AJ, Rogers LM, Noble KN, Manning SD, Damo SM, Aronoff DM, Townsend SD, Gaddy JA. Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus. Chembiochem. 2021 Jun 15;22(12):2124-2133. doi: 10.1002/cbic.202100016. Epub 2021 Mar 23. PMID: 33755306; PMCID: PMC8254657.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 52 entries